Stolwyck,
This might be a bit of fancy but if you consider the rise in market capitalization of Genetech since it released news oF Avastin being approved by FDA (rise equals 536m shares by a rise of $13 equals about $7bill) and then equate that back to Progen with its approx 35m shares on issue, an equivalent Sp is about $200. However Genetech probably manufacture their product and enjoy all the benefits from it whereas PGL would only be recieving licence fees so they may attract say 20% of the total value. A bit more back of the envelope and this 20% would perhaps allow a SP for PGL approaching $40. Not forgetting at all that PI-88 is potentially three times better than Avastin so $40 not all that unrealistic.
Stolwyck,This might be a bit of fancy but if you consider the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.30M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 44.5¢ | 44.0¢ | $226.2K | 509.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 158238 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 257803 | 9 |
View Market Depth
| Last trade - 15.23pm 23/07/2024 (20 minute delay) ? |
| PGL (ASX) Chart |